wagnerap

The Indian Council of Medical Research (ICMR) successfully completed a clinical trial on an injectable male contraceptive, according to The New York Post.

“The product is ready, with only regulatory approvals pending,” said Dr. R.S. Sharma, a senior scientist with ICMR. “The trials are over, including extended, Phase 3 clinical trials for which 303 candidates were recruited with a 97.3% success rate and no reported side effects. The product can safely be called the world’s first male contraceptive.”

The birth control method lasts approximately 13 years. The process involves injecting a polymer, called styrene maleic anhydride, into the vas deferens. The injection blocks sperm from leaving the testicles and includes anesthesia.

In the U.S., male contraceptives are being researched as well. Vasalgel is a similar product that is not available in the market yet. Furthermore, a male birth control pill is being developed but is about 10 years away from being readily available to the public.

“When I think about this whole concept of contraception that you have to inject … it’s too graphic,” said a 33-year-old male. “Our [testicles] are like family jewels, so if I have to resort to using any kind of contraceptive, I’d rather go for a pill.”

The Indian Council of Medical Research successfully completed a clinical trial on an injectable male contraceptive. Now, the researchers must convince men to allow them to inject the contraceptive into their groin region.

View the Full Story Here.

Comments

Science, Futurology, and Analysis

FEATURED
COMMUNITY